ASEP Medical Holdings (ASEP Medical Holdings) EV-to-EBIT : -1.74 (As of May. 21, 2024)

View and export this data going back to 2022. Start your Free Trial

What is ASEP Medical Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, ASEP Medical Holdings's Enterprise Value is $10.86 Mil. ASEP Medical Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-6.24 Mil. Therefore, ASEP Medical Holdings's EV-to-EBIT for today is -1.74.

The historical rank and industry rank for ASEP Medical Holdings's EV-to-EBIT or its related term are showing as below:

SEPSF' s EV-to-EBIT Range Over the Past 10 Years
Min: -86.23 Med: 0 Max: 0
Current: -1.76

SEPSF's EV-to-EBIT is ranked worse than
100% of 427 companies
in the Biotechnology industry
Industry Median: 10.09 vs SEPSF: -1.76

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. ASEP Medical Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was $20.49 Mil. ASEP Medical Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-6.24 Mil. ASEP Medical Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -30.45%.

ASEP Medical Holdings EV-to-EBIT Historical Data

The historical data trend for ASEP Medical Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASEP Medical Holdings EV-to-EBIT Chart

ASEP Medical Holdings Annual Data

Trend

Dec21

Dec22

Dec23

EV-to-EBIT

-15.65

-8.33

-2.66

ASEP Medical Holdings Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial							-8.33	-4.43	-5.18	-3.24	-2.66

Competitive Comparison of ASEP Medical Holdings's EV-to-EBIT

For the Biotechnology subindustry, ASEP Medical Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ASEP Medical Holdings's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ASEP Medical Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where ASEP Medical Holdings's EV-to-EBIT falls into.

ASEP Medical Holdings EV-to-EBIT Calculation

ASEP Medical Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	10.861	/	-6.238
	=	-1.74

ASEP Medical Holdings's current Enterprise Value is $10.86 Mil.
ASEP Medical Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.24 Mil.

ASEP Medical Holdings (OTCPK:SEPSF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

ASEP Medical Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-6.238	/	20.488363106
	=	-30.45 %

ASEP Medical Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was $20.49 Mil.
ASEP Medical Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.24 Mil.

ASEP Medical Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of ASEP Medical Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

ASEP Medical Holdings (ASEP Medical Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ASEP Medical Holdings Inc (OTCPK:SEPSF) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

JJ8:Germany ASEP:Canada

Address

730 View Street, Suite 420, Victoria, BC, CAN, V8W 3Y7

Website

https://www.asepmedical.com

ASEP Medical Holdings Inc is a biotechnology firm pursuing the commercialization of broad-spectrum peptide technology. The Company is dedicated to addressing the global issue of antibiotic failure by developing novel solutions for significant unmet medical needs in human medicine and is engaged in the business of acquiring research and development assets, technology, or businesses in life sciences and medical diagnostics.